The Effect of 12-week Dietary Intake of Syrup Containing CoQ10 and Collagen on Dermis Density and Other Skin Parameters

Wrinkles Clinical Trial

— Q10-collagen  

Official title:

The Effect of 12-week Dietary Intake of Syrup Containing CoQ10 and Collagen on Dermis Density and Other Skin Parameters: Randomised Double-blind Placebo-controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03811756
• Other study ID #: VIST F4F Q10-collagen 01-2018
• Status: Completed
• Phase: N/A
• Start date: October 15, 2018
• Est. completion date: July 10, 2019

Study information

• Verified date: December 2019
• Source: Higher School of Applied Sciences (VIST)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Placebo controlled double-blind multi-dose comparative study of the effects of coenzyme Q10 and collagen formulation with improved water-solubility in healthy adults.

One group (test group) will receive investigational product - test syrup (daily dose 10 mL:

fish collagen: 4000 mg, water soluble CoQ10 (Q10Vital®): 50 mg, vitamin C: 80 mg, vitamin A:

920 μg, biotin: 150 μg) and the other (placebo group) placebo syrup without those active ingredients. Participants will test continuous administration of placebo or investigational product for 12 weeks in order to demonstrate and assess multiple-dose effects on skin condition and signs of skin aging.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 34
• Est. completion date: July 10, 2019
• Est. primary completion date: February 19, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 40 Years to 65 Years

Eligibility

Inclusion Criteria:

• Caucasian female volunteers aged between 40 and 65 years at the time of the signature of Informed consent form (ICF),

• Signed Informed consent form (ICF),

• Fitzpatrick skin phototypes II and III,

• Signs of skin aging,

• In good health condition,

• Willingness to avoid a consumption of any food supplements containing CoQ10 and other antioxidants, collagen or vitamins during the study,

• Willingness to follow all study procedures and keeping a diary during the study (to follow their compliance and palatability).

Exclusion Criteria:

• Pregnancy or breastfeeding,

• Known or suspected allergy to any ingredient of the tested products,

• Changes in dietary habits and dietary supplementation in last three months prior to inclusion,

• Regular use of food supplements containing CoQ10 or other antioxidants, collagen or other protein-based food supplements, vitamin A, vitamin E or biotin in last three months prior to inclusion,

• Veganism,

• Changes in cosmetic facial and body care routine in last month prior to inclusion,

• Diagnosed and uncontrolled/untreated/unregulated disease,

• Any clinically significant history of serious metabolic disease, digestive tract disease, liver disease, kidney disease, haematological disease,

• Acute skin diseases,

• Skin pigmentation disorders,

• Increased cholesterol and use of cholesterol lowering drugs (statins),

• Anticipated sunbathing or solarium visits before or during the study,

• Invasive rejuvenation treatments (e.g. needle rollers, needle mesotherapy, deep/medium-deep chemical peels etc.) in last 6 months prior to study entry,

• Non-invasive rejuvenation treatments (e.g. radiofrequency, electrotherapy, ultrasound therapy) in last 2 months prior to study entry,

• Mental incapacity that precludes adequate understanding or cooperation.

Related Conditions & MeSH terms

• Dermis Density
• Dermis Thickness
• Skin Hydration
• Trans Epidermal Water Loss (TEWL)
• Wrinkles

Intervention

Dietary Supplement:
• Test syrup containing CoQ10 and collagen
Test group will receive investigational product - test syrup (daily dose 10 mL: fish collagen: 4000 mg, water soluble CoQ10 (Q10Vital®): 50 mg, vitamin C: 80 mg, vitamin A: 920 µg, biotin: 150 µg); continuous administration of investigational product for 12 weeks.
• Placebo syrup
Placebo group will receive placebo syrup without active ingredients. (daily dose 10 mL: fish collagen: 0 mg, water soluble CoQ10 (Q10Vital®): 0 mg, vitamin C: 0 mg, vitamin A: 0 µg, biotin: 0 µg); continous administration of placebo product for 12 weeks.

Locations

Country	Name	City	State
Slovenia	Higher School of Applied Sciences, Institute of Cosmetics	Ljubljana

Sponsors (4)

Lead Sponsor	Collaborator
Higher School of Applied Sciences (VIST)	European Regional Development Fund, Ministry of Education, Science and Sport, Republic of Slovenia, Valens Int. d.o.o., Slovenija

Country where clinical trial is conducted

Slovenia, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Influence of investigational product in relation to placebo product on dermis density assessed through dermis intensity measurement	Significant change of dermis density from baseline in test group, in comparison to placebo group after 12 weeks of dietary supplementation with study product is expected. Dermis density will be assessed through ultrasonographic dermis intensity measurement.	12 weeks
Secondary	Influence of the investigational product in relation to placebo product on skin elasticity assessed through measurements of viscoelasticity	For assessments of skin viscoelasticity measurements will be performed. Significant change of skin viscoeasticity from baseline in test group, in comparison to placebo group after 12 weeks of dietary supplementation with study product is expected.	12 weeks
Secondary	Influence of the investigational product in relation to placebo product on skin hydration	Assessment of the effects of the investigational product on skin hydration after 12 weeks of dietary supplementation. Skin hydration measurements will be performed using conductance principle.	12 weeks
Secondary	Influence of the investigational product in relation to placebo product on TEWL	Assessment of the effects of investigational product on transepidermal water loss after 12 weeks of dietary supplementation. TEWL measurements will be performed using open chambre principle.	12 weeks
Secondary	Influence of investigational product in relation to placebo product on dermis thickness	Significant change of dermis thickness from baseline in test group, in comparison to placebo group after 12 weeks of dietary supplementation with study product is expected. Dermis density will be assessed using ultrasonography.	12 weeks
Secondary	Influence of investigational product in relation to placebo product on wrinkles will be assessed using wrinkle area fraction measurements	Assessment of the effects of investigational product on facial wrinkles after 12 weeks of dietary supplementation will be done using wrinkle area fraction measurements.	12 weeks